SECOND AMENDED AND RESTATED CONTINGENT LICENSE AGREEMENTContingent License Agreement • September 4th, 2007 • Matritech Inc/De/ • In vitro & in vivo diagnostic substances • Delaware
This SECOND AMENDED AND RESTATED CONTINGENT LICENSE AGREEMENT (this “Agreement”) is made as of the 30th day of August, 2007 (the “Effective Date”), by and among MATRITECH, INC. a corporation organized under the laws of the State of Delaware (the “Licensor”), and SDS CAPITAL GROUP SPC, LTD. (the “Licensee”), as collateral agent for the holders (the “Holders”) of the Series A Notes, Series B Notes and Series C Notes (as defined below) (in such capacity, the “Collateral Agent”).
CONTINGENT LICENSE AGREEMENTContingent License Agreement • January 18th, 2006 • Matritech Inc/De/ • In vitro & in vivo diagnostic substances • Delaware
This CONTINGENT LICENSE AGREEMENT (this “Agreement”) is made as of the 13th day of January, 2006 (the “Effective Date”), by and among MATRITECH, INC. a corporation organized under the laws of the State of Delaware (the “Licensor”), and SDS CAPITAL PARTNERS SPC, LTD. (the “Licensee”), as collateral agent for the holders (the “Holders”) of the Notes (as defined below) (in such capacity, the “Collateral Agent”).
